Glauben Landskron
Overview
Explore the profile of Glauben Landskron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
2689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quintanilla M, Santapau D, Diaz E, Valenzuela Martinez I, Medina N, Landskron G, et al.
Sci Rep
. 2024 Nov;
14(1):29260.
PMID: 39587197
Alcohol use disorder (AUD) represents a public health crisis with few FDA-approved medications for its treatment. Growing evidence supports the key role of the bidirectional communication between the gut microbiota...
2.
Balboa E, Saud F, Parra-Ruiz C, De la Fuente M, Landskron G, Zanlungo S
Front Pharmacol
. 2024 Jul;
15:1406784.
PMID: 38978979
The global prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is increasing, now affecting 25%-30% of the population worldwide. MASLD, characterized by hepatic steatosis, results from an imbalance in lipid...
3.
Fierro-Arenas A, Landskron G, Camhi-Vainroj I, Basterrechea B, Parada-Venegas D, Lobos-Gonzalez L, et al.
Life Sci
. 2024 Jun;
351:122851.
PMID: 38897345
Aims: Pannexin-1 (PANX1) is a hemichannel that releases ATP upon opening, initiating inflammation, cell proliferation, and migration. However, the role of PANX1 channels in colon cancer remains poorly understood, thus...
4.
Astorga J, Gasaly N, Dubois-Camacho K, De la Fuente M, Landskron G, Faber K, et al.
Front Immunol
. 2024 Mar;
15:1384162.
PMID: 38469317
[This corrects the article DOI: 10.3389/fimmu.2022.1028953.].
5.
Astorga J, Gasaly N, Dubois-Camacho K, De la Fuente M, Landskron G, Faber K, et al.
Front Immunol
. 2022 Dec;
13:1028953.
PMID: 36466902
Inflammatory Bowel Disease (IBD) is characterized by a loss of intestinal barrier function caused by an aberrant interaction between the immune response and the gut microbiota. In IBD, imbalance in...
6.
Landskron G, Dubois-Camacho K, Orellana-Serradell O, De la Fuente M, Parada-Venegas D, Bitran M, et al.
Cells
. 2022 Jun;
11(12).
PMID: 35741034
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) and can be treated with glucocorticoids (GC), although some patients are unresponsive to this therapy. The transcription factor LRH-1/ is critical...
7.
Garcia-Gonzalez P, Tempio F, Fuentes C, Merino C, Vargas L, Simon V, et al.
Front Immunol
. 2021 Nov;
12:769059.
PMID: 34745145
The prognosis of severe COVID-19 patients has motivated research communities to uncover mechanisms of SARS-CoV-2 pathogenesis also on a regional level. In this work, we aimed to understand the immunological...
8.
Soongsathitanon J, Jamjuntra P, Sumransub N, Yangngam S, De la Fuente M, Landskron G, et al.
J Immunol Res
. 2021 Aug;
2021:8840066.
PMID: 34337083
Signals from the tumor microenvironment (TME) have a profound influence on the maintenance and progression of cancers. Chronic inflammation and the infiltration of immune cells in breast cancer (BC) have...
9.
Hanus M, Parada-Venegas D, Landskron G, Wielandt A, Hurtado C, Alvarez K, et al.
Front Immunol
. 2021 Apr;
12:612826.
PMID: 33841394
Colorectal cancer (CRC) is one of the most common cancers worldwide. As with other cancers, CRC is a multifactorial disease due to the combined effect of genetic and environmental factors....
10.
Ezquer F, Quintanilla M, Moya-Flores F, Morales P, Munita J, Olivares B, et al.
Addict Biol
. 2021 Jan;
26(4):e13018.
PMID: 33508889
Gut microbiota is known to be transferred from the mother to their offspring. This study determines whether the innate microbiota of rats selectively bred for generations as high alcohol drinkers...